Is there a place for nutritional supplements in the treatment of idiopathic male infertility?

Archivio Italiano di Urologia e Andrologia

Volumn 86, Issue 3, 2014, Pages 164-170

  Arcaniolo, Davide ^a   Favilla, Vincenzo ^b   Tiscione, Daniele ^c   Pisano, Francesca ^d   Bozzini, Giorgio ^e   Creta, Massimiliano ^a   Gentile, Giorgio ^f   Fabris, Filippo Menchini ^g   Pavan, Nicola ^h   Veneziano, Italo Antonio ⁱ   Cai, Tommaso ^d  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b UNIVERSITY OF CATANIA   (Italy)

^c SANTA CHIARA HOSPITAL   (Italy)

^d UNIVERSITY OF TURIN   (Italy)

^e UNIVERSITY OF MILAN   (Italy)

^f UNIVERSITY OF BOLOGNA   (Italy)

^g UNIVERSITY OF PISA   (Italy)

^h UNIVERSITY OF TRIESTE   (Italy)

ⁱ Ospedale Madonna Delle Grazie   (Italy)

Author keywords

Male fertility; N Acetyl Carnitine; Oligoasthenotera tozoospermia; Phytotherapy; Semen parameters; Vitamin E

Indexed keywords

ACETYLCYSTEINE; ALPHA TOCOPHEROL; ARGININE; ASCORBIC ACID; CARNITINE; GLUTATHIONE; N ACETYL CARNITINE; RETINOL; SELENIUM; UBIDECARENONE; UNCLASSIFIED DRUG; ZINC;

CLINICAL TRIAL (TOPIC); DIET SUPPLEMENTATION; HUMAN; IDIOPATHIC DISEASE; MALE; MALE INFERTILITY; MORPHOLOGY; PREGNANCY RATE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SPERM; SPERMATOZOON COUNT; SPERMATOZOON MOTILITY; TREATMENT OUTCOME;

EID: 84929471193     PISSN: 11243562     EISSN: 22824197     Source Type: Journal    
DOI: 10.4081/aiua.2014.3.164     Document Type: Review

References (76)

1. Sharlip ID, Jarow JP, Belker AM, et al. Best practice policies for male infertility Fertil Steril. 2002; 77:873-882
2. World Health Organization. WHO Manual for the Standardized Investigation and Diagnosis of the Infertile Couple. Cambridge: Cambridge University Press, 2000.
3. Cooper TG, Noonan E, von Eckardstein S, et al. World Health Organization reference values for human semen characteristics. Hum Reprod Update. 2010; 16:231-45.
4. Jungwirth A, Diemer T, Dohle GR, Giwercman A, Kopa Z, Krausz C, Tournaye H members of the European Association of Urology (EAU) Guidelines Office. Guidelines on Male Infertility. In: EAU Gui de lines, edition presented at the 28th EAU Annual Congress, Milan 2013.
5. Tremellen K. Oxidative stress and male infertility-A clinical perspective. Hum. Reprod. Update. 2008; 14:243-258.
6. Agarwal A, Sharma RK, Nallella KP, et al. Reactive oxygen species as an independent marker of male factor infertility. Fertil. Steril. 2006: 86:878-885.
7. Aitken R, Baker M. Oxidative stress and male reproductive biology. Reprod Fertil Dev. 2004; 16:581-588.
8. Agarwal A,Saleh RA,Bedaiwy MA. Role of reactive oxygen species in the pathophysiology of human reproduction. Fertil Steril. 2003;79:829-843.
9. Smith R, Vantman D, Ponce J, et al. Total antioxidant capacity of human seminal plasma Human Reproduction 1996; 11:1655-1660.
10. Pahune PP, Choudhari AR, Muley PA. The total antioxidant power of semen and its correlation with the fertility potential of human male subjects. J Clin Diagn Res. 20 13; 7:991-995.
11. Palamanda JR, Kehrer JR. Involvement of vitamin E and protein thiols in the inhibition of microsomal lipid peroxidation by glutathione. Lipids. 1993; 23:427-443.
12. Brigelius-Flohe R, Traber MG. Vitamin E: function and metabolism. FASEB J. 1999; 13:1145-1155.
13. Kessopoulou E, Powers HJ, Sharma KK, et al. A double-blind randomi zed placebo crossover controlled trial using the antioxidant vitamin E to treat reactive oxygen species associated male infertility. Fert Steril. 1995; 64:825-831.
14. Ross C, Morriss A, Khairy M, et al. A systematic review of the effect of oral antioxidants on male infertility. Reprod Biomed Online. 2010; 20:711-723.
15. Eskenazi B, Kidd SA, Marks AR, et al. Antioxidant intake is associated with semen quality in healthy men. Hum Reprod (Oxf). 2005; 20:1006-1012.
16. Suleiman SA, Ali ME, Zaki ZMS, et al. Lipid peroxidation and human sperm motility: protective role of vitamin E. J Androl. 1996; 17:530-537.
17. Greco E, Iacobelli M, Rienzi L, et al. Reduction of the incidence of sperm DNA fragmentation by oral antioxidant treatment. J Androl. 2005; 26:349-353.
18. Kobori Y, Ota S, Sato R, et al. Antioxidant cosupplementation therapy with vitamin C, vitamin E, an d coenzyme Q10 in patients with oligoasthenozoospermia. Arch Ital Urol Androl. 2014; 86:1-4.
19. Linster CL, Van Schaftingen E. Vitamin C. Biosynthesis, recycling and degradation in mammals. FEBS J. 2007; 274:1-22.
20. Baker HW, Brindle J, Irvine DS, Aitken RJ. Protective effect of antioxidants on the impairment of sperm motility by activated polymorphonuclear leukocytes. Fert Steril. 1996; 65:411-419.
21. Omu AE, al-Azemi MK, Kehinde EO, et al. Indications of the mechanisms involved in improved sperm parameters by zinc therapy. Med Prin Pract. 2008; 17:108-116.
22. Thiele JJ, Friesleben HJ, Fuchs J, Ochsendorf FR. Ascorbic acid and urate in human seminal plasma: determination and interrelationships with chemiluminescence in washed semen. Hum Reprod (Oxf). 1995; 10:110-115.
23. Mendiola J, Torres-Cantero AM, Vioque J, et al. A low intake of antioxidant nutrients is associated with poor semen quality in patients attending fertility clinics. Fert Steril. 2010; 93:1128-113 3.
24. Dawson EB, Harris WA, Teter MC, Powell LC. Effect of ascorbic acid supplementation on the sperm quality of smokers. Fertil Steril. 1992; 58:1034-1039.
25. Kamal-Eldi n A, Appelqvist LA. The chemistry and antioxidant properties of tocopherols and tocotrienols. Lipids. 1996; 31:671- 701.
26. Scott R, MacPherson A, Yates RW, et al. The effect of oral selenium supplementation on human sperm motil ity. Br J Urol. 1998; 82:76-80.
27. Galatioto GP, Gravina GL, Angelozzi G, et al.. May antioxidant therapy improve sperm parameters of men with persistent oligospermia after retrograde embolization for v aricocele? World J Urol. 2008; 26:97-102.
28. Appleton J. Arginine: clinical potential of a semi-essential amino. Altern Med Rev. 2002; 7:512-522.
29. Sinclair S. Male infertility: nutritional and environmental considerations. Altern Med Rev. 2000; 5:28-38.
30. Tanimura J. Studies on arginine in human semen. Part II. The effects of medication with L-arginine-HCl on male infertility. Bull Osaka Med Sch. 1967;13:84-89.
31. Schachter A, Goldman JA, Zukerman Z. Treatment of oligospermia with the amino acid arginine. J Urol. 1973; 110:311-313.
32. de Aloysio D, Mantuano R, Mauloni M, Nicoletti G. The clinical use of arginine aspartate in male infertility. Acta Eur Fertil. 1982; 13:133-167.
33. Miroueh A. Effect of arginine on oligospermia. Fertil Steril. 1970; 21:217-219.
34. Pryor JP, Bl andy JP, Evans P, et al. Controlled clinical trial of arginine for infertile men with oligozoospermia. Br J Urol. 1978; 50:47-50.
35. Palmero S, Bottazzi C, Costa M, et al. Metabolic effects of Lcarnitine on prepubertal rat Sertoli cells. Horm Metab Res. 2000; 32:87-90
36. Vicari E, LaVignera S, Calogero A. Antioxidant treatment with carnitines is effective in infertile patients with prostatovesiculoepididymitis and elevated seminal leukocyte concentrations after treatment with nonsteroidal anti-inflammatory compounds. Fertil Steril. 2002; 6:1203-1208.
37. Lenzi A, Sgro P, Salac one P, et al. A placebo-controlled doubleblind randomized trial in the use of combined L-carnitine and L-acetylcarnitine treatment in men with asthenozoospermia. Fertil Steril. 2004; 81:1578-1584.
38. Ba lercia G, Regoli F, Armeni T, et al. Placebo-controlled doubleblind randomized trial on the use of L-carnitine, L-acetylcarnitine, or combined L-carnitine and Lacetylcarnitine in men with idiopathic asthenozoospermia. Fertil Steril. 2005; 84:662-671.
39. Cavallini G, Ferraretti AP, Gianarolli L, et al. Cinnoxicam and L carnitine/acetyl-L-carnitine treatment for idiopathic and varicocoeleassociated oligoasthenospermia. J Andro l. 2004; 25:761-770.
40. De Rosa M, Boggia B, Amalfi B, et al.. Correlation between seminal carnitine and functional spermatozoal characteristics in men with semen dysfunction of various origins. Drugs RD . 2005; 6:1-9.
41. Moncada ML, Vicari E, Cimino C, et al.. Effect of acetylcarnitine treatment in oligoasthenospermic patients. Acta Eur Fertil. 1992; 23:221-224.
42. Costa M, Canale D, Filicori M, et al. L-Carnitine in idiopathic asthenozoospermia: a multicenter study. Italian Study Group on Carnitine and Male Infertility. Andrologia. 1994; 26:155-159.
43. Vicar i E, Calogero AE. Effects of treatment with carnitines in infertile patients with prostato-vesiculo-epididymitis. Hum Reprod (Oxf). 2001; 16:2338-2342.
44. Vitali G, Parente R, Melotti C. Carnitine supplementation in human idiopathic asthenospermia: clinical results. Drugs Exp Clin Res. 1995; 21:157-159.
45. Sigman M, Glass S, Campagnone J, Pryor JL. Carnitine for the treatment of idiopathic asthenospermia: a randomized, doubleblind, placebo-controlled trial. Fertil Steril. 2006; 85:1409-1414.
46. Busetto GM, Kovere ch A, Messano M, et al. Prospective open-label study on the efficacy and tolerability of a combination of nutritional supplements in primary infertile patients with idiopathic astenoteratozoospermia Arch Ital Urol Androl. 2012; 84:137-40.
47. Littarru GP, Tiano L. Clinical aspects of coenzyme Q10: an update. Nutrition. 2010; 26:250-254.
48. Balercia G, Buldreghini E, Vignini A, et al. Coenzyme Q10 treatment in infertile men with idiopathic asthenozoospermia: a placebo-controlled, double-blind randomized trial. Fertil Steril. 2009; 91:1785-1792.
49. Balercia G, Mancini A, Paggi F, e t al. Coenzyme Q10 and male infertility. J Endocrinol Invest. 2009; 32:626-692.
50. Safarinejad MR. Efficacy of coenzyme Q10 on semen parameters, sperm function and reproductive hormones in infertile men. J Urol. 2009; 182:237-248.
51. Festa R,Giacchi E,Raimondo S,et al. Coenzyme Q10 supplementation in infertile men with low-grade varicocele: an open uncontrolled pilot study Andrologia. 2013 Aug 22, doi: 10.1111/and.12152.
52. Safarinejad MR, Safarinejad S, Shafiei N, Safarinejad S. Effects of the reduced form of coenzyme Q10 (ubiquinol) on semen parameters in men with idiopathic infertility: a double-b lind, placebo controlled, randomized study. J Urol. 2012; 188:526-31.
53. Nadjarzadeh A, Shidfar F, Amirjannati N, et al. Effect of Coenzyme Q10 supplementation on antioxidant enzymes activity a nd oxidative stress of seminal plasma: a double-blind randomised clinical trial.Andrologia. 2014; 46:177-83.
54. Safarinejad MR. The effect of coenzyme Q10 supplementation on partner pregnancy rate in infertile men with idiopathic oligoasthenoteratozoospermia: an open-label prospective study. Int Urol Nephrol. 2012; 44:689-700.
55. Lafuente R, Gonzá lez-Comadrán M, Solà I, et al. Coenzyme Q10 and male infertility: a meta-analysis. J Assist Rep. 30:1147-56.
56. Lenzi A, Lombardo F, Gandini L, et al. Glutathione therapy for male infertility. Arch Androl. 1992; 29:65-68.
57. Lenzi A, Culasso F, Gandini L, et al. Placebo-controlled, double blind, cross-over trial of glutathione therapy in male infertility. Hum Reprod (Oxf). 1993; 8:1657-1662.
58. Lenzi A, Picardo M, Gandini L, et al. Glutathione treatment of dyspermia: effect on the lipoperoxidation process. Hum Reprod (Oxf). 1994; 9:2044-2050.
59. Zembron-Lacny A, Slowinska-Lisowska M, Szygula Z, et al. The comparison of antioxidant and hematological properties of N-acetylcysteine and alpha-lipoic acid in physically active males. Physiol Res. 2009; 58:855-861.
60. . Oeda T, Henkel R, Ohmori H, Schill WB. Scavenging effect of Nacetyl-L-cysteine against reactive oxygen species in human semen: a possible therapeutic modality for male factor infertility? Andrologia. 1997; 29:125-131 .
61. Ciftci H, Verit A, Savas M, et al. Effects of N-acetylcysteine on semen parameters and oxidative/antioxidant status. Urology. 2009; 74:73-76.
62. Safarinejad MR, S afarinejad S. Efficacy of selenium and/or Nacetylcysteine for improving semen parameters in infertile men: a doubleblind, placebo controlled, randomized study. J Urol. 2009; 181:741-751.
63. Brown KM, Ar thur JR. Selenium, selenoproteins and human health: a review. Public Health Nutr. 2001; 4:593-599.
64. Ursini F, Heim S, Kiess M, et al. Dual function of the selenoprotein PHGPx during sperm maturation. Science. 1999; 285:1393-1396.
65. Burton GW, Traber MG. Vitamin E: antioxidant activity, biokinetics, and bioavailability. Annu Rev Nutr. 1990; 10:357-382.
66. Vezina D, Mauffette F, Roberts KD, Bleau G. Selenium-vitamin E supplementation in infertile men. Effects on semen parameters and micronutrient levels and distribution. Biol Trace Elem Res.1996; 53:65-83.
67. Keskes-Ammar L, Feki-Chakroun N, Rebai T, et al. Sperm oxidative stress and the effect of an oral vitamin E and selenium supplement on semen quality in infertile men. Arch Androl. 2003; 49:83- 94.
68. Ebisch IM, Thomas CM, Peters WH, et al. The importance of folate, zinc and antioxidants in the pathogenesis and prevention of subfertility. Hum Reprod (Oxf). 2007; 13:163-174.
69. Prasad AS. Zinc in human health: effect of zinc on immune cells. Mol Med. 2008; 14:353-357.
70. Zhao YI, Zhao H, Zhai X, et al. Effects of Zn deficiency, antioxidants, and lo w-dose radiation on diabetic oxidative damage and cell death in the testis. Toxicol Mech Methods. 2013; 23:42-7.
71. Azizollahi G, Azizollahi S, Babaei H, et al. Effects of supplement therapy on sperm parameters, protamine content and acrosomal integrity of varicocelectomized subjects. J Assist Reprod Genet. 2013; 30:593-9.
72. Raigani M, Yaghmaei B, Amirjannti N, et al. The micronutrient supplements, zinc sulphate and folic acid, did not ameliorate sperm functional parameters in oligoasthenoteratozoospermic men. Andrologia. 2013 Oct 23.
73. Showell MG,Brown J,Yazdani A,et al. Antioxidants for male subfertility. Cochrane Database Syst Rev. 2011;1: CD007411.
74. Clark NA, Will M, Moravek MB, Fisseha S. A systematic review of the evidence for complementary and alternative medicine in infertility. Int J Gynaecol Obstet. 2013; 122:202-6.
75. . Imamovic Kumalic S, Pinter B. Review of Clinical Trials on Oligoasthenoteratozoospermia. Biomed Res Int. 2014; 2014:426951.
76. Comhaire F, Decleer W. Comparing the effectiveness of infertility treatments by numbers needed to treat (NNT). Andrologia. 2012; 44:401-4.